[Carcinogenic properties of derivatives of symmetric triazine].
D000232:Adenofibroma / Q000139:chemically induced; D000236:Adenoma / Q000139:chemically induced; D000818:Animals; D002273:Carcinogens; D005260:Female; D006392:Hemangioma, Cavernous / Q000139:chemically induced; D006540:Herbicides; D008067:Lipoma / Q000139:chemically induced; D008113:Liver Neoplasms / Q000139:chemically induced; D008175:Lung Neoplasms / Q000139:chemically induced; D008207:Lymphatic Metastasis; D008228:Lymphoma, Non-Hodgkin / Q000139:chemically induced; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced; D051379:Mice; D009374:Neoplasms, Experimental / Q000139:chemically induced*; D051381:Rats; D012417:Rumen; D012509:Sarcoma / Q000139:chemically induced; D014227:Triazines
D002273:Carcinogens; D006540:Herbicides; D014227:Triazines
O kantserogennykh svoĭstvakh proizvodnykh simmetrichnogo triazina.